Diligence memo · auto-generated · as of July 2, 2026

DispatchHealth Holdings, Inc.

DispatchHealth Holdings, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

DispatchHealth Holdings, Inc. operates in Other Health Care, based in DENVER.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

DispatchHealth Holdings, Inc. has raised $578M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).

Largest single filing: $259M on 2022-10-31.

Most recent recorded round closed around 2022-10-31.

Valuation (modeled)modeled

Provath models DispatchHealth Holdings, Inc. at approximately $3.7B (range $1.4B–$6.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.17× the median modeled value of Series D+ Other Health Care companies in 2022–2024 (17 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 3.7 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 1.9× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 100% of Other Health Care peers (5377 compared).

Modeled value ranks above 99% of those peers.

Closest niche peers: United Digestive Holdings, LLC, Zimmer Biomet Holdings, Inc., Main Street Rural, Inc., Richmond Buyer L.P., Thirty Madison, Inc..

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.